ObvioHealth
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ObvioHealth - overview
Established
2017
Location
New York, NY, US
Primary Industry
Healthcare IT
About
Based in New York, US, and founded in 2017, ObvioHealth operates as a digital health company. The company was founded by its CEO Ivan Jarry. In July 2021, ObvioHealth raised USD 31 million in series B funding, led by investors Dedalus Group and Novotech Health Holdings Pte. Ltd.
The company’s product line includes a virtual clinical trial platform and a BYOD (bring your own device) app, which is a mobile application that allows patients to complete (electronic patient-reported outcomes) ePRO in clinical trials. In addition, the company offers a wide range of services such as digital recruitment services, remote patient monitoring, data analysis, visualization, and reporting. The company plans to use the funds raised in July 2021 to expand the IT capabilities of its ecosystem and plans to increase its hiring.
Current Investors
Tikehau Capital, IQVIA, Inc., Sprim Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT
Website
www.obviohealth.com
Verticals
HealthTech, Mobile Apps
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.